
- Nebraska Oncology Society
- The Nebraska Chapter of the American College of Cardiology
- Nebraska Rheumatology Society
- Medication-Assisted Treatment
- Nebraska Dermatology Society
- Nebraska Neurological Society
- Nebraska Radiological Society
Playback speed
10 seconds
2020 ASCO Highlights on Advanced CRC: Does mFOLFIRINOX Show DFS Benefit vs. Chemoradiation Among LARC Patients? Is Encorafenib+Cetuximab+/-Binimetinib Effective for BRAF V600E Mutations? What Is the ORR With T-DXd in HER2+ Metastatic Disease?
By
Nebraska Oncology Society
FEATURING
George Kim
By
Nebraska Oncology Society
FEATURING
George Kim
0 views
November 30, 2020
Comments 0
Login to view comments.
Click here to Login
Nebraska Oncology Society